NCT05466396 Lung Health of Early COPD: A Multi-center Cohort Study
| NCT ID | NCT05466396 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ting YANG |
| Condition | COPD |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,550 participants |
| Start Date | 2022-08-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,550 participants in total. It began in 2022-08-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a multi-center, prospective, cohort study in early COPD patients. This study aims to elucidate the lung function decline and its association with smoking and other risk factors. Other biomarkers and image markers from chest CT scan are also analyzed to investigate the lung function in early COPD patients.
Eligibility Criteria
Inclusion Criteria: 1. Gender: male or female 2. Age: 35-75 years old 3. post-bronchodilator spirometry: FEV1/FVC \< 0.8 and FEV1%pred ≥80% Exclusion Criteria: 1. Other diseases may affect lung function, like lung cancer, bronchiectasis, interstitial lung disease or chest surgery. 2. BMI \> 35 kg/m2 3. Dementia or other severe neurological disease 4. Pregnancy 5. Conditions that contraindicated lung function test
Contact & Investigator
Ting Yang, M.D.
PRINCIPAL INVESTIGATOR
China-Japan Friendship Hospital
Frequently Asked Questions
Who can join the NCT05466396 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, up to 75 Years, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05466396 currently recruiting?
Yes, NCT05466396 is actively recruiting participants. Contact the research team at huangke_zryy@163.com for enrollment information.
Where is the NCT05466396 trial being conducted?
This trial is being conducted at Beijing, China, Zunyi, China.
Who is sponsoring the NCT05466396 clinical trial?
NCT05466396 is sponsored by Ting YANG. The principal investigator is Ting Yang, M.D. at China-Japan Friendship Hospital. The trial plans to enroll 1,550 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.